Blockade of phosphatidylinositol 3-kinase PI3Kδ or PI3Kγ reduces IL-17 and ameliorates imiquimod-induced psoriasis-like dermatitis.

MLA

Roller, Anne, et al. “Blockade of Phosphatidylinositol 3-Kinase PI3Kδ or PI3Kγ Reduces IL-17 and Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis.” Journal of Immunology (Baltimore, Md. : 1950), vol. 189, no. 9, Nov. 2012, pp. 4612–20. EBSCOhost, https://doi.org/10.4049/jimmunol.1103173.

APA

Roller, A., Perino, A., Dapavo, P., Soro, E., Okkenhaug, K., Hirsch, E., & Ji, H. (2012). Blockade of phosphatidylinositol 3-kinase PI3Kδ or PI3Kγ reduces IL-17 and ameliorates imiquimod-induced psoriasis-like dermatitis. Journal of Immunology (Baltimore, Md. : 1950), 189(9), 4612–4620. https://doi.org/10.4049/jimmunol.1103173

Chicago

Roller, Anne, Alessia Perino, Paolo Dapavo, Elisabetta Soro, Klaus Okkenhaug, Emilio Hirsch, and Hong Ji. 2012. “Blockade of Phosphatidylinositol 3-Kinase PI3Kδ or PI3Kγ Reduces IL-17 and Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis.” Journal of Immunology (Baltimore, Md. : 1950) 189 (9): 4612–20. doi:10.4049/jimmunol.1103173.